Second Line Immunosuppresant Drug Monographs
News posted: 17.03.25 Post by: Dr Alexandra Johnson
Time to read: ~ minutes, give or take.
The British Oncology Pharmacy Association (BOPA) and the IOCN have collaborated to formulate drug monographs for second line immunosupressive agents. These drug monographs aim to guide for healthcare professionals on the prescribing and monitoring of second line agents when used in the management of immune related adverse events caused by treatment with immune-checkpoint inhibitors.
Currentlty BOPA have produced drug monographs on Abatacept, Infliximab, Methotrexate, MMF, Tacrolimus, Tocilizumab and Vedolizumab.